A blood test to detect lung cancer mutations and monitor treatment response: from concept to clinical application.

Impact claim (as reported by the claimant) from REF 2021 impact case studies. Evidence status: source reported.

Organisation

University of Cambridge

Source reference

10ef4159-0909-48d1-9b3f-406c71c85e97

Jurisdiction

United Kingdom

Licence

CC BY 4.0. © the submitting university; via UKRI REF 2021. Changed: summary of the impact only, formatting removed.

Impact case study submitted by University of Cambridge to REF 2021 · Unit of assessment: Clinical Medicine · Summary impact type: Technological · Imported because it names a tracked health-data resource

Source: https://results2021.ref.ac.uk/impact/10ef4159-0909-48d1-9b3f-406c71c85e97. Captured 2026-10-23.

Limitations: The submitting university's own account of its impact, written for assessment. OpenHDI has not checked the claim or its corroborating sources. A cited paper is underpinning research the university names; the case study does not establish that any particular data use caused the impact.